EMG
FATE icon

ETF Managers Group’s Fate Therapeutics FATE Stock Holding History

ETF Managers Group’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$36.2K Buy
+6,359
New +$38.4K ﹤0.01% 666
2021
Q2 		– Sell
-2,263
Closed -$168K – 706
2021
Q1 		$168K Sell
2,263
-13,323
-85% -$1.28M ﹤0.01% 619
2020
Q4 		$1.46M Buy
15,586
+5,367
+53% +$333K 0.03% 215
2020
Q3 		$403K Sell
10,219
-6,356
-38% -$222K 0.01% 356
2020
Q2 		$541K Buy
+16,575
New +$494K 0.02% 254

Other funds holding FATE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

ETF Managers Group's FATE Position: Q1 2023 in Review

ETF Managers Group opened a new position in Fate Therapeutics (FATE) in Q1 2023: 6,359 shares worth $36.2K. The stake represents ﹤0.01% of the portfolio and ranks #666 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in FATE as recently as Q1 2021.

ETF Managers Group first reported a position in FATE in Q2 2020 and has held it in 5 quarters since. The position peaked at $1.46M in Q4 2020. 181 funds tracked by Wall St. Rank hold FATE as of Q1 2023.

  • ETF Managers Group held 6,359 shares of Fate Therapeutics worth $36.2K as of Q1 2023.
  • Fate Therapeutics was a new ETF Managers Group position in Q1 2023.
  • Fate Therapeutics made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #666 holding.
  • ETF Managers Group first reported a position in Fate Therapeutics in Q2 2020 and has held it in 5 quarters since.
  • ETF Managers Group's Fate Therapeutics position peaked at $1.46M in Q4 2020.
  • 181 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.